Pfizer

Pfizer, a global biopharmaceutical leader founded in 1849, operates at the forefront of healthcare innovation. Specializing in the research, development, manufacturing, and marketing of medicines and vaccines, Pfizer addresses critical therapeutic areas including oncology, internal medicine, inflammation and immunology, and vaccines. The company's extensive portfolio aims to prevent, treat, and manage diseases worldwide, contributing significantly to global public health. With its primary operations anchored in New York City, Pfizer's reach is extensive, and for detailed geographic insights, Learn about Pfizer's global headquarters.

With an employee base exceeding 10,000 employees, Pfizer leverages its vast human capital and state-of-the-art facilities to drive its mission. The company's product development spans a wide range of pharmaceuticals, from small-molecule drugs to advanced therapies like gene therapy and vaccines, including well-known products like Prevnar and the Epipen auto-injector. Pfizer's commitment to scientific advancement is evident in its robust pipeline and dedication to bringing innovative treatments to patients. To understand the people behind these advancements, Meet Pfizer's team.

Financially, Pfizer reported a substantial revenue of $63.3B, underscoring its significant market presence. The company has also secured funding, such as a $1.25B debt round in March 2020, to support its ongoing operations and expansion. Pfizer competes in a dynamic market against major players like Merck, Novartis, and Lilly, among others. Its strategic focus on biopharmaceuticals and healthcare solutions positions it as a key entity in the global pharmaceutical landscape. Further details on its financial performance are available via Explore financial highlights.